Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption
Several degenerative amyloid diseases, with no fully effective treatment, affect millions of people worldwide. These pathologies—amyloidoses—are known to be associated with the formation of ordered protein aggregates and highly stable and insoluble amyloid fibrils, which are deposited in multiple ti...
Main Authors: | Elisabete Ferreira, Zaida L. Almeida, Pedro F. Cruz, Marta Silva e Sousa, Paula Veríssimo, Rui M. M. Brito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/1/391 |
Similar Items
-
Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01) -
Structure and Aggregation Mechanisms in Amyloids
by: Zaida L. Almeida, et al.
Published: (2020-03-01) -
Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01) -
The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation
by: Adam S. Knier, et al.
Published: (2022-12-01) -
Amyloid Aggregates of Smooth-Muscle Titin Impair Cell Adhesion
by: Alexander G. Bobylev, et al.
Published: (2021-04-01)